Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to 18F-FDG-PET/CT.

Donatienne Van WeehaegheOlivier GheysensVincent VandecaveyePatrick SchöffskiKoen Van LaereChristophe M Deroose

Published in: BMC cancer (2018)

This case illustrates that metabolic response can occur in GIST lesions without morphological response after third line regorafinib treatment. Furthermore this is the first case in literature to show regorafinib response on PET.

Keyphrases

systematic review
computed tomography
bone marrow
positron emission tomography
pet imaging
smoking cessation